Increased antimicrobial resistance during the COVID-19 pandemic

Chih Cheng Lai, Shey Ying Chen, Wen Chien Ko, Po Ren Hsueh

研究成果: Review article同行評審

49 引文 斯高帕斯(Scopus)


In addition to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the current status of the COVID-19 (coronavirus disease 2019) pandemic. There has been a rapid increase in multidrug-resistant organisms (MDROs), including extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae, carbapenem-resistant New Delhi metallo-β-lactamase (NDM)-producing Enterobacterales, Acinetobacter baumannii, methicillin-resistant Staphylococcus aureus (MRSA), pan-echinocandin-resistant Candida glabrata and multi-triazole-resistant Aspergillus fumigatus. The cause is multifactorial and is particularly related to high rates of antimicrobial agent utilisation in COVID-19 patients with a relatively low rate of co- or secondary infection. Appropriate prescription and optimised use of antimicrobials according to the principles of antimicrobial stewardship as well as quality diagnosis and aggressive infection control measures may help prevent the occurrence of MDROs during this pandemic.

期刊International journal of antimicrobial agents
出版狀態Published - 2021 4月

All Science Journal Classification (ASJC) codes

  • 微生物學(醫學)
  • 傳染性疾病
  • 藥學(醫學)


深入研究「Increased antimicrobial resistance during the COVID-19 pandemic」主題。共同形成了獨特的指紋。